Israeli CT software company Medic Vision has successfully completed a round of funding worth 2.6 million euros ($3.5 million U.S.), undertaken by Bridge Investment Group of Cleveland.
The Tirat Carmel company, whose SafeCT technology reduces noise on CT images and facilitates use of lower radiation dose examination protocols, received U.S. Food and Drug Administration (FDA) 510(k) clearance earlier this year, and announced that it has added three customers recently in the U.S.
